In the BioHarmony Drug Report Database

"Preview" Icon

Goserelin

Zoladex (goserelin) is a protein pharmaceutical. Goserelin was first approved as Zoladex on 1989-12-29. The pharmaceutical is active against gonadotropin-releasing hormone receptor. Zoladex’s patent is valid until 2022-04-13 (FDA).

 

Trade Name

 

Zoladex
 

Common Name

 

goserelin
 

ChEMBL ID

 

CHEMBL1201247
 

Indication

 

 

Drug Class

 

Prehormones or hormone-release stimulating peptides

Image (chem structure or protein)

Goserelin structure rendering